: The Role of Keppra in the Treatment of Tremor in Multiple Sclerosis
Phase 1
- Conditions
- Multiple Sclerosis
- Registration Number
- EUCTR2005-003903-35-GB
- Lead Sponsor
- ewcastle-upon-Tyne Hospitals NHS Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1. McDonald criteria for diagnosis of MS (McDonald, 2001)16
2. Clinical evidence of Cerebellar Tremor.
3. Aged 18-60
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
1. There is evidence of a further significant MS relapse during the trial
2. Evidence of resting tremor, or Holmes (rubral) tremor
3. Patients already on specific anti-tremor medication
4. Pregnant or breast feeding mothers
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method